Peter Galatin is an expert in the field of Oncology. He studied medicine at Virginia Commonwealth University School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". Peter Galatin is a published doctor and has 3 publications published. The lastest was: 'Phase I trial of oblimersen (Genasense(R)) and gemcitabine in refractory and advanced malignancies.' He is registered with Medicare and accepts Medicare payments.
|
Dr. Philip S. Creger, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rupinder Kaur, MD
|
|
Dr. Joyce P. Orndorff, MD
|
|
Dr. Steven M. Scates, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Daniel F. Haber, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Thomas T. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Martin D. Rubenstein, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Anne R. Uyei, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Dayton S. Misfeldt, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bryant C. Sheh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Martha C. Man, MD
This Doctor is OpenDoctor Recommended.
|